Skip to main content

William Rote

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About William Rote

Travere Therapeutics, Inc. reported in an 8-K filed June 16, 2026 that William Rote retired as Chief Research Officer, effective February 17, 2027. The proxy statement of Travere Therapeutics, Inc. reports total compensation of $2,256,465 for William Rote in fiscal 2025, including a base salary of $522,334. Disclosed compensation is on record for 9 fiscal years.

“On June 12, 2026, William Rote, Ph.D., Chief Research Officer of the Company, provided notice to the Company of his intention to retire from employment with the Company, effective February 17, 2027 (the "Retirement Date"), the 10 year anniversary of his employment with the Company.”
Travere Therapeutics, Inc. Form 8-K, filed June 16, 2026 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Travere Therapeutics, Inc. (TVTX) $522,334 $2,256,465
2024 Travere Therapeutics, Inc. (TVTX) $502,834 $1,516,646
2023 Travere Therapeutics, Inc. (TVTX) $488,417 $2,053,099
2022 Travere Therapeutics, Inc. (TVTX) $470,204 $2,033,381
2021 Travere Therapeutics, Inc. (TVTX) $460,881 $1,946,740
2020 Travere Therapeutics, Inc. (TVTX) $447,474 $1,657,674
2019 Travere Therapeutics, Inc. (TVTX) $432,858 $1,310,226
2018 Travere Therapeutics, Inc. (TVTX) $420,250 $1,618,525
2017 Travere Therapeutics, Inc. (TVTX) $363,481 $1,853,644

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.